Cyclana Bio
Cyclana Bio is addressing a need to better serve millions of women by developing physiologically relevant models and utilising AI-driven multi-scale data integration to enable the discovery of druggable targets to improve treatment outcomes.
Cyclana Bio has raised €5.8M across 1 funding round from 5 investors, most recently a Pre-Seed round in Oct 2025. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.cycletherapeutics.org ↗
Total raised
€5.8M
€5,754,402
Funding rounds
1
Investors
5
distinct backers
Active since
2025-10
latest 2025-10
Funding by year
EUR raised per yearCyclana Bio — funding by year — interactive chart.
Data table
| Cyclana Bio — funding by year | |
|---|---|
| 2025 | €5.8M |
Signals
High confidenceRaise-next likelihood34
base rate 24% for Pre-Seed
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-22 | Pre-Seed | €5.8M | Angel Investors,Cocoa VC,Eka Ventures,NFX,Wilbe Capital | View deal → |